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The immunoglobulin heavy chain locus undergoes a series of DNA rearrangements and
modiﬁcations to achieve the construction and expression of individual antibody heavy chain
genes in B cells. These events affect variable regions, through VDJ joining and subsequent
somatic hypermutation, and constant regions through class switch recombination (CSR).
Levels of IgH expression are also regulated during B cell development, resulting in high
levels of secreted antibodies from fully differentiated plasma cells. Regulation of these
events has been attributed primarily to two cis-elements that work from long distances
on their target sequences, i.e., an ∼1 kb intronic enhancer, Eμ, located between the V
region segments and the most 5′ constant region gene, Cμ; and an ∼40 kb 3′ regulatory
region (3′ RR) that is located downstream of the most 3′ CH gene, Cα. The 3′ RR is a
candidate for an “end” of B cell-speciﬁc regulation of the Igh locus.The 3′ RR contains sev-
eral B cell-speciﬁc enhancers associated with DNase I hypersensitive sites (hs1–4), which
are essential for CSR and for high levels of IgH expression in plasma cells. Downstream
of this enhancer-containing region is a region of high-density CTCF binding sites, which
extends through hs5, 6, and 7 and further downstream. CTCF, with its enhancer-blocking
activities, has been associated with all mammalian insulators and implicated in multiple
chromosomal interactions. Here we address the 3′ RR CTCF-binding region as a potential
insulator of the Igh locus, an independent regulatory element and a predicted modulator
of the activity of 3′ RR enhancers. Using chromosome conformation capture technology,
chromatin immunoprecipitation, and genetic approaches, we have found that the 3′ RR
with its CTCF-binding region interacts with target sequences in theVH, Eμ, and CH regions
through DNA looping as regulated by protein binding.This region impacts on B cell-speciﬁc
Igh processes at different stages of B cell development.
Keywords: immunoglobulin heavy chain gene locus, enhancers, insulators, CTCF, class switch recombination,
Pax5, chromosome conformation capture (3C) assay
Igh GENES AND THEIR DNA REARRANGEMENTS
AND MUTATION
The immunoglobulin heavy chain gene locus (Igh) undergoes
an amazing array of DNA rearrangements and mutagenic events
during B cell differentiation (reviewed in Max, 2008). A general
question is how these DNA modiﬁcations are normally achieved
during B cell development without mistakes that result in malig-
nant transformation. Our studies have focused on a regulatory
region that acts at long distances on target Igh sequences essential
for these DNA rearrangement and mutagenic events (reviewed in
Pinaud et al., 2011).
The Igh locus extends for ∼3 Mb and contains coding seg-
ments for constructing a diverse repertoire of variable region
genes, through recombination of VH (variable), DH (diversity),
and JH (joining) segments, as well as for constant region (CH)
genes that, when translated, confer different functional capabilities
on antibody molecules. During bone marrow B cell develop-
ment, the locus undergoes sequential DNA rearrangement and
mutational events that generate an enormous range of antibody
heavy chain genes, each specifying individual antigen binding sites
associated with speciﬁc constant regions. The initial event, i.e.,
recombinase-activator genes (RAG)-mediated V(D)J joining,
involves ﬁrst, a DJ join, and then V to DJ joining, both accompa-
nied by deletions of intervening sequences; these lead to expression
of a IgM heavy chain bearing a single variable region. Successful
expression of one allele halts rearrangements on the other allele
(allelic exclusion) and promptsVJ joining on the light chain allele.
Upon leaving the bonemarrow, theB cell with itsH2L2 surface IgM
is poised to receive signals through antigen and other receptors for
T cell surface proteins and secreted cytokines that trigger further
DNA targeted events, such as class switch recombination (CSR)
and somatic hypermutation. CSR is initiated by germline tran-
scription (GT) of the non-IgMCH gene to which subsequentDNA
rearrangement will occur. The DNA rearrangement event results
in a shift of the VDJ gene segment from its position upstream of
μ to upstream of γ, ε or α genes; as in VDJ joining, intervening
DNA is deleted as a circle. VH-hypermutation results, upon anti-
gen selection, in B cells with higher afﬁnity antigen-binding sites.
Both CSR and somatic hypermutation depend on the activity of
activation-dependent cytidine deaminase (AID). In fully differ-
entiated plasma cells, heavy chain gene expression occurs at high
levels. These multiple processes of VDJ joining, GT and CSR, and
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increased Igh expression levels require tight regulation to con-
tain these potentially mutagenic events within the conﬁnes of the
Igh locus.
THE 3′ RR CONTAINS AN ENHANCER MODULE AND A
HIGH-DENSITY CTCF-BINDING REGION
Twomajor long distance Igh control elements have been identiﬁed.
Our focus here is on a large (∼50 kb) 3′ regulatory region (3′ RR),
located downstream of the CH genes (reviewed in Pinaud et al.,
2011) and schematized in Figure 1. A second well-characterized
control element is an ∼1 kb intronic enhancer, Eμ, positioned
between theV,D, and J segments and theCH genes, which is critical
for VDJ joining (reviewed in Max, 2008).The murine 3′ RR con-
tains a 5′ 28 kb segment, which has four enhancers that collectively
support GT,CSR, and high levels of IgH expression in plasma cells.
An ∼10 kb 3′ segment contains a region of high-density CTCF-
and Pax5-binding sites with insulator activity. Pax5, a transcrip-
tion factor essential for B cell identity (reviewed in Cobaleda et al.,
2007), is associated with 3′ RR enhancers as well. Our studies have
shown that the 3′ RR interacts at long distances with a number
of Igh target sites, as part of its inﬂuence on CSR and regulation
of Igh expression. This entire region is a candidate for a down-
stream “end” of B cell-speciﬁc regulation of the Igh locus. At the
upstreamV region end, the Igh locus begins in the general vicinity
of telomeric sequences (mouse chr. 12, human chr. 14), suggestive
of a natural boundary. At the 3′ CH-end, beyond the terminus
of the 3′ RR, hole (Tmem121), Crip1/2, and mta1 are the nearest
non-Igh downstream genes (all in the same inverted transcrip-
tional orientation compared to the Igh locus) followed by the rest
of the chromosome (Zhou et al., 2002a). There are multiple kinds
of regulatory elements in this 3′ RR. Three of the four enhancers
located in the 5′ segment of the murine 3′ RR form an ∼25 kb
palindrome, in which the central hs1.2 enhancer is ﬂanked by
virtually identical terminal enhancers hs3A and hs3B (Saleque
et al., 1997). A fourth enhancer, hs4, lies 3′ of hs3B in a sepa-
rate 3 kb structural and functional unit (Michaelson et al., 1995;
Saleque et al., 1997). Hs4 and the palindromic region vary in their
acquisition of DNase I hypersensitivity during B cell maturation
(Giannini et al., 1993); hs4 becomes hypersensitive early in B cell
development and remains so throughout, while the palindromic
enhancers become hypersensitive only later in B cell maturation.
A similar 3′ RR (hs3, hs1.2, hs4) is located downstream of each
of the two Cα genes in the human Igh locus (Chen and Bir-
shtein, 1996, 1997; Mills et al., 1997; Sepulveda et al., 2004a,b;
Frezza et al., 2009).
As a potential“end”of B cell-speciﬁc regulation of the Igh locus,
how might the 3′ RR help to focus DNA rearrangement events on
the Igh locus and prevent inherently mutagenic events like DNA
rearrangements and mutations from encroaching into neighbor-
ing downstream genes? We predicted that the 3′ RR might house
an insulator region with CTCF as a major functional contribu-
tor, similar to insulator regions found in other loci (Phillips and
Corces, 2009; Amouyal, 2010; Yang and Corces, 2011). In fact,
(and before the era of high-throughput genomic analyses), EMSA
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FIGURE 1 | Schematic of 3′ RR.The top line shows relative positions of V, D,
and J segments, the intronic enhancer, Eμ, and the CH genes. The 3
′ RR
region is located downstream of the Cα gene of the Igh locus and has two
major modules: an ∼28 kb region containing four enhancers, that, collectively,
are essential for GT and CSR and for high levels of Igh expression in plasma
cells. The 5′ 3 enhancers, hs3A, hs1.2, and hs3B, occupy a palindromic region
(blue box), with hs3A and hs3B in inverted orientation at the ends of the
region. A fourth enhancer hs4 occupies a separate structural and functional
unit (red oval). In the 10 kb downstream, there is a high-density of CTCF
binding sites associated with DNase I hypersensitive sites hs5, hs6, and hs7,
and with a segment 4 kb further downstream, termed “38” because it is
located ∼38 kb from the beginning of the 3′ RR (with BAC199 M11 as a
reference, Genbank AF450245; purple rectangle). This region also contains
interspersed Pax5 sites.
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with recombinant CTCF on 50 consecutive overlappingDNA frag-
ments identiﬁed multiple CTCF sites (Garrett et al., 2005). These
were associated with additional DNase I hs sites, hs5, 6, and 7, and
with a segment 4 kb downstreamof hs7, which because it is located
38 kb from the beginning of the 3′ RR has been termed “38.”
Hs5 and hs7 were shown to confer insulator activity in a cell line
assay (Garrett et al., 2005). Analysis of EMSAwith nuclear extracts
from B cell lines using supershift studies with speciﬁc antibodies
for CTCF and Pax5 showed that this entire hs5–7-“38” region
contained interspersed CTCF- and Pax5-binding sites (Chatterjee
et al., 2011). Because Pax5 is a regulator of 3′ RR enhancers, these
data suggested that Pax5 might help coordinate the actions of the
enhancer-containing region with the insulator region. Here we
describe studies of the contribution of the 3′ RR to Igh regulation
throughout B cell development; in levels of H chain expression in
plasma cells, in GT and CSR in B cells, and in use of VH genes
in VDJ joining in pro- and pre-B cells. For the most part, these
involve the formation of loops associating components of the 3′
RRwith target Igh sequences, as described in the following sections
and as schematized in Figure 2.
THE 3′ RR AFFECTS H CHAIN EXPRESSION IN PLASMA CELLS
THROUGH CONTACTS WITH Igh TARGET SEQUENCES
A role for the 3′ RR in high levels of Igh expression in plasma
cells was inferred when we established that the entire 3′ RR was
deleted in a mouse plasma cell line that had lost 90% of its Igh
expression levels (Gregor and Morrison, 1986; Michaelson et al.,
1995). That the 3′ RR could loop to engage target Igh sequences
was predicted from studies of another mouse plasma cell line,
in which we detected an inversion of a segment extending from
FIGURE 2 |The 3′ RR interacts via looping with many different target
Igh sequences during B cell development. During VDJ joining in pro-
and pre-B cells, the 3′ RR interacts with two CTCF sites upstream of DH
(red arrow). Also in pre-B cells, the 3′ RR is involved in allelic regulation
(brown arrow). In B cells, interaction of the 3′ RR with I/switch regions is
associated with GT and subsequent CSR (purple arrows). In plasma cells
(lower right), the 3′ RR interacts with the expressed VDJ region and the
intronic enhancer. Also in malignant plasma cells, the translocated c-myc
oncogene interacts in cis by looping with the 3′ RR (Ju et al., 2007).
Studies show some evidence that CTCF binding sites in the 3′ RR have
some insulation activity (gray box) that is detected to impact as far as
the “hole” gene. However, CTCF sites associated with downstream
genes appear to provide an over-riding local inﬂuence (as discussed in
the text).
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expressed VH gene sequences to the 3′ RR palindromic region
(Calvo et al., 1991; Ju et al., 2007). Resolution of a loop formed
by interactions between the VH gene and the 3′ RR is the sim-
plest intermediate to account for this inversion. Documentation
of such a loop structure came upon implementation of the chro-
mosome conformation capture (3C) method in a plasma cell line:
here we showed physical interactions involving 3′ RR enhancers
and its CTCF-binding region with the JH sequence that was part
of the expressed VH gene. The adjacent Eμ sequences were not
essential for this interaction (Ju et al., 2007). The contacts asso-
ciated with chromatin loop formation were severely disrupted in
a different MPC11 variant, whose expressed Igh gene had been
rendered non-functional by substitution of the hs1.2 enhancer by
the NeoR gene (Ju et al., 2007). These data implied that an intact
3′ RR was essential for H chain expression in plasma cells and
that H chain expression depended on intact physical interaction
in cis of the 3′ RR with the expressed VH gene. An extension of
these observations from cell lines to mice has derived from tar-
geted deletion of the entire enhancer-containing region of the 3′
RR in mice, which has conﬁrmed a critical role of the 3′ RR in
promoting high levels of Igh expression in plasma cells (Vincent-
Fabert et al., 2010).
Efforts to identify proteins that support loop formation
and concomitant Igh expression used a loss-of-function strat-
egy employing lentiviral-mediated shRNA directed against CTCF,
Oct-2, and OBF-1/OCA-B (Ju et al., 2011) in the MPC11 plasma
cell line. In no case did we see effects on Igh expression. We con-
clude that proteins other than those targeted were required to
support H chain expression, or that residual levels of CTCF, Oct-
2, and/or OBF-1/OCA-B remaining after the knock-down were
sufﬁcient, or that these factors act in a redundant fashion and
that simultaneous knock down of multiple factors is required for
a decrease of Igh chain expression.
TARGETED DELETIONS OF 3′ RR ENHANCERS REVEAL THEIR
INVOLVEMENT IN GT AND CSR
The impact of targeted deletions of 3′ RR enhancers in mouse by
a number of investigators has revealed their importance for two
successive steps of the CSR process, i.e., transcription through
CH switch regions, followed by CSR. Deletion of the hs3B and
hs4 region of the 3′ RR reduced switching to all isotypes except
IgG1 (Cogne et al., 1994; Manis et al., 1998). The contribution to
GT and CSR of the I/switch regions and of the 3′ RR enhancers
has been fully demonstrated (reviewed in (Cogne and Birshtein,
2004). 3C studies on mature B cells undergoing CSR revealed
interactions between the 3′ RR and switch regions through which
transcription occurs prior to CSR (Wuerffel et al., 2007). These
interactions were severely reduced in B cells frommice in which 3′
RRenhancers hs3B andhs4were deleted. These data supported the
importance of loop interactions between the 3′ RR and its target
switch sequences for CSR. The distances involved range from ∼15
to ∼150 kb.
3C experiments also revealed cytokine-responsive chromo-
somal conformation involving the 3′ RR during GT and CSR
(Wuerffel et al., 2007; Yan et al., 2011). Cytokine treatments that
fostered switching to a particular isotype not only stimulate tran-
scription of switch sequences of that isotype by activating the I
region promoter upstream of switch sequences, but also result
in speciﬁc increased 3C interactions between the 3′ RR and the
isotype-speciﬁc switch region. Interestingly, a double deletion of
hs3A and hs3B generated by the Eckhardt laboratory had no effect
on either transcription or CSR (Yan et al., 2011). However, we
found that in this doubly deleted mouse, isotype-speciﬁc interac-
tions between switch regions and the 3′ RR ordinarily enhanced by
cytokines were already at a high level in resting B cells, and there
was a concomitant increase in interactions between the remaining
3′ RR enhancers, hs1.2 and hs4. These observations suggested that
hs3A and hs3B modulate a functional hs1.2-hs4 3′ RR enhancer
unit (Yan et al., 2011).
In fact, GT and CSR are generally unaffected after individual
deletions of each of the four 3′ RR enhancers, including hs1.2
and hs4 (Manis et al., 1998; Vincent-Fabert et al., 2009; Bebin
et al., 2010; Dunnick et al., 2011). Interestingly, a distinctive (but
similarly functional) enhancer unit remains after each individual
enhancer deletion, e.g., hs1.2, hs3B, hs4 (when hs3A is deleted);
hs3A, hs3B, hs4 (when hs1.2 is deleted) and so on. This implies
considerable ﬂexibility in the structure and function of the 3′ RR
enhancer unit, a point that is addressed further below. In all, the
essential role of 3′ RR enhancers in GT and CSR can be met by
their multiple alternative functional interactions with each other
and with target switch sequences; these inﬂuence isotype-speciﬁc
switching in response to cytokine signaling.
TARGETED DELETION OF 3′ RR CTCF BINDING SITES HS5–7
Our studies have shown that during GT and CSR, the multi-
ple modules of the 3′ RR, i.e., enhancers and the CTCF-binding
region hs5–7, interact with I/switch regions and with the Pax5
transcription factor. Pax5 (reviewed in (Cobaleda et al., 2007)
is essential for B cell identity and, through reporter assays, was
shown to play an important role in regulating murine 3′ RR
enhancers (Singh and Birshtein, 1993, 1996). To determine the
function of the CTCF-binding region, we generated hs5–7 KO
mice (Volpi et al., 2012). B cells from hs5–7 KO mice showed
essentially normal GT and CSR except for a modest increase in
IgG1+ cells upon switching in culture. One possibility to account
for these observations is that interactions of Igh sequences with
the CTCF/Pax5-binding site-rich hs5–7 region are secondary to
the role of the 3′ RR enhancers and are not essential during
CSR. Another possibility is that the deletion did not eliminate
all candidate CTCF-binding sites. In fact, ChIP/Seq data (Deg-
ner et al., 2009) showed that the hs5–7 KO left behind a limited
number of CTCF sites in the 3′ RR region, and other CTCF
sites associated with each non-Igh downstream gene (R. Casellas,
personal communication). Potentially, even a fraction of CTCF
sites in this region or other CTCF-interacting sites are sufﬁcient
for appropriate biological activity. Similarly, we had anticipated
that a reduction in insulator activity resulting from deletion of
a large group of CTCF sites from the 3′ RR would enable the
upstream unaffected 3′ RR enhancers to promote expression of
downstream, non-Igh genes. However, our studies revealed only
a modest increase in expression of the nearest downstream gene,
Tmem121, while further downstream genes were unaffected (Volpi
et al., 2012). It appears that local regulation of downstream genes
by their ownCTCF sites provides a back-upmechanism to restrain
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inappropriately regulated activity of the Igh locus from inﬂicting
damage on non-Igh genes.
INFLUENCE OF 3′ RR CTCF-BINDING REGION
ON VDJ JOINING
CTCF has been described as a “master weaver of the genome”
(Phillips and Corces, 2009). Thousands of genomic CTCF sites
have been mapped, including those within the Igh locus (Garrett
et al., 2005; Degner et al., 2009, 2011). Moving upstream (3′ to 5′)
of the high-density CTCF-binding region in the hs5–7 region of
the 3′ RR past the CH and JH regions that are devoid of CTCF
sites, the CTCF sites that are closest to the 3′ RR are two sites
located 5′ of the most 5′ DH gene; by 3C, these have been shown
to interact with the 3′ RR. Functional inactivation of the two D-
associated CTCF sites abrogated normal VDJ joining (Guo et al.,
2011); as a result, they have been named intergenic control region
1 (IGCR1). These studies imply a role of CTCF in VDJ joining.
In fact, functional inactivation of CTCF in pro-B cells by shRNA
(Degner et al., 2011) resulted in an increased distance between the
interacting 3′ RR andDH/CTCF sequences, i.e., a reduction inVH-
locus contraction, and an increase in anti-sense transcription in
DH andVH regions. To determine, therefore, whether 3′ RRCTCF
sites that bind to DH/CTCF are critical for the role of DH/CTCF
in VDJ joining, we assessed a mouse with a targeted deletion of
CTCF binding sites in the hs5–7 region of the 3′ RR (Volpi et al.,
2012). Here, we were surprised to ﬁnd essentially normal levels
of VDJ joining in hs5–7 KO pro- and pre-B cells, except for a
detectable increase in DQ52-JH3 usage at multiple stages of B cell
development. In addition, there was a modest, albeit statistically
signiﬁcant reduction in Igh locus contraction, and an increase by
twofold over wild-type in the use of proximal VH7183 genes while
distal VHJ558 usage was unaffected. Notably, allelic exclusion was
correctly maintained. Although these data uncover an effect of the
3′ RR-CTCF-binding region on the Igh locus when VDJ joining is
occurring presumptively through interactions of this region with
DH/CTCF, they also imply the presence of considerable backups
for proper Igh regulation.
Pax5 AND CTCF AS REGULATORS OF THE 3′ RR
DURING CSR
Pax5
As a step toward further understanding mechanisms that control
the 3′ RR, we have identiﬁed transcription factors that regulate
3′ RR enhancer activity. Experiments showed that the four 3′ RR
enhancers are regulated by a common set of transcription factors,
namely Oct-binding proteins, NFκB, and Pax5 (Michaelson et al.,
1996), which could synergize for concerted repression (Singh and
Birshtein, 1996) or for concerted activation of 3′ RR enhancers
(Michaelson et al., 1996). YY1 has also been implicated (Gordon
et al., 2003). Importantly, Pax5 appears to regulate each of the 3′
RR enhancers as well as the CTCF-binding region. Using chro-
matin immunoprecipitation (ChIP), we found that as B cells are
induced to switch by culture with LPS +/- IL4, Pax5 shifts in its
association with modules of the 3′ RR (Chatterjee et al., 2011). In
resting B cells, Pax5 binds predominantly to hs4. At 48 h when
GT and switch region-3′ RR interactions are at a peak, Pax5 has
shifted away from hs4 to bind to upstream enhancer (hs1.2) and
downstream insulator (hs7) ﬂanking sites. At 96 h, when CSR has
been completed, Pax5 regains hs4 binding as seen in resting B cells.
Regardless of whether switching to γ3 or γ2b occurred by stimu-
lation with LPS, or to γ1 through stimulation by LPS + IL4, the
Pax5 pattern of binding to the 3′ RR was similar.
When we compared B cells that successfully undergo sequen-
tial steps in switch recombination with those that are deﬁcient in
GT and/or CSR (Chatterjee et al., 2011), we found that the Pax5-
binding pattern to the 3′ RR is mechanistically associated with
CSR. For example, stimulation of NFκB p50−/− cells for 48 h with
LPS + IL4 shows deﬁciency in normal GT; accordingly, the Pax5
proﬁle is different from normal B cells. Pax5 continues to bind to
hs4 although acquiring binding to hs1.2. In cells stimulated with
anti-IgM + IL4, which undergo normal GT but fail to switch, the
Pax5-binding pattern at 48 h is like that of cells stimulated by
LPS + /-IL4, but at 96 h, the pattern is disrupted. Collectively,
these data suggest that dynamic changes in Pax5 binding to the
3′ RR are supported by an isotype-independent scaffold on which
GT and CSR occur.
CTCF
To determine whether changes in CTCF binding to the 3′ RR were
similarly associated with CSR, we analyzed binding of CTCF and
its cofactor cohesin, this latter consisting of multiple subunits,
including Rad21 (Chatterjee et al., 2011). In contrast to changes in
Pax5 binding, we found relatively stable interactions of CTCFwith
the high-density CTCF-binding region in hs5–7 and“38”through-
out the steps in GT and CSR that occurred in cells cultured with
LPS + /-IL4. Also as expected, together with CTCF, Rad21 bound
preferentially to hs7 upon stimulation with either LPS + /-IL4 or
with anti-IgM + IL4. However, in resting B cells and independent
of CTCF,Rad21 additionally bound to hs1.2 at low levels, and then
at substantially increased levels at 48 h of stimulation before bind-
ing at reduced levels again to hs1.2 at 96 h. A similar pattern of
CTCF-independent Rad21 binding to hs1.2 was detected in cells
stimulated with anti-IgM + IL4.
Collectively, these data showed that CTCF and cohesin bind-
ing to the 3′ RR, both to cognate CTCF sites and independent
of known CTCF sites, appear to contribute to a framework for
the 3′ RR, while Pax5 has dynamic interactions with its binding
sites. We have proposed (Chatterjee et al., 2011) that the multiple
Pax5-binding sites in 3′ RR enhancers could support a scaffold
structure: various enhancer deletions or shifts in enhancer occu-
pancy could take place, leaving behind varying constellations of
functional Pax5 sites.
REGULATION OF 3′ RR BY DNA METHYLATION
We predicted that the 3′ RR is subject to epigenetic regulation as
it acquires its functional capability. The 3′ RR essentially can be
divided into two regions under separate epigenetic control, the 5′
palindromic enhancers and the more 3′ hs4-“38” region. Begin-
ning in pro-B cells, the hs4-“38” region is associated with marks
of active chromatin (Garrett et al., 2005) and with DNA demethy-
lation (Giambra et al., 2008), which appear to be set in place by
expression of Pax5 and linker histone H1. The upstream palin-
dromic enhancers – hs3A-hs1.2-hs3B – acquire both epigenetic
marks in B and plasma cells (Giambra et al., 2008).
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BOX1 | Regulation ofmethylation and chromatinmodifications
of 3′ RR during B cell development
1. In pro-B cells, the hs4 enhancer and the CTCF-binding region
hs5-“38” are demethylated and showmarks of active chromatin.
These marks are retained during B cell development. In B and
plasma cells, the palindromic enhancers hs3A-1.2-3B acquire
both epigenetic marks.
2. A polymorphic region between hs4 and hs5 reveals demethyla-
tion speciﬁc for the expressed allele in pre-B cells.
3. The 3′ RR in resting B cells is mostly methylated. In B cells
stimulated to undergo class switching, the 3′ RR becomes pro-
gressively demethylated with limited accompanying changes in
chromatin marks.
The two Igh alleles in themouse 70Z/3 pre-B cell line (C57Bl/6-
derived and DBA/J-derived) can be distinguished by their stage
during VDJ joining, their association with a polymorphic DNA
segment that is subject to DNA demethylation (Giambra et al.,
2008), and by the formation of loops involving the 3′ RR
(Ju et al., 2011). The expressed VDJ-joined, C57Bl/6-derived,
allele is associated in cis with a 3′ RR containing a deletion of
hs3A-hs1.2 (with no apparent impact on Igh expression; Saleque
et al., 1999). The polymorphic region located between hs4 and
hs5 on this allele is demethylated. In contrast, the unexpressed
DJ-joined allele (DBA/J-derived) fails to undergo looping in cis
with its intact 3′ RR, and the hs4-hs5 sequence remains methy-
lated. These data reinforce the role of the 3′ RR in cis-regulation
of the Igh locus and imply that DNA demethylation in the 3′
RR, looping and Igh VDJ rearrangement and expression may be
associated.
Interestingly, B cells stimulated for GT and CSR do not reveal
any signiﬁcant changes in chromatin marks of the 3′ RR (Garrett
et al., 2005). Instead,we have identiﬁed progressiveDNAdemethy-
lation of the 3′ RR (Giambra et al., 2008) and (Giambra, V., in
preparation). These observations suggest that in resting B cells
prior to stimulation for CSR, the 3′ RR is poised in its chromatin
proﬁle. We predict that DNA demethylation is associated with
architectural changes by which the 3′ RR inﬂuences GT, CSR, and
high levels of Igh expression in plasma cells. These epigenetic alter-
ations of the 3′ RR during B cell development are summarized in
Box 1.
DO Igh DNA REPLICATION PATTERNS SPECIFY ANOTHER
TERMINUS OF THE Igh LOCUS?
Various landmarks might demarcate functional termini for the
Igh locus; (1) the distinctive cluster of CTCF sites in hs5–7
that is located downstream of the CH part of the locus and (2)
∼20 kb further downstream, the nearest non-Igh downstream
gene, Tmem121, i.e., hole. In collaborative studies (Michaelson
et al., 1997; Ermakova et al., 1999; Zhou et al., 2002a,b, 2005), we
identiﬁed a replication origin downstream of Tmem121 that is
also a candidate for a functional B cell-speciﬁc terminus of Igh
regulation. These studies showed that the Igh locus had differ-
ent temporal patterns of DNA replication in non-B cells and at
various stages of B cell development. In non-B cells, an origin
of replication was identiﬁed ∼11 kb downstream of Tmem121,
which is ∼30 kb downstream of the hs5–7 region and ∼76–79 kb
downstream of the Cα gene. DNA sequences downstream of this
landmark all replicated early in S. Beginning at this origin and
moving upstream, i.e., 3′ to 5′, the 500 kb region within which CH,
JH, DH, and VH7183 sequences were located replicated progres-
sively later in S. This was consistent with the absence of activated
origins of replication in this region. Sequences further upstream
of the 500 kb transition region all replicated late in S. However, in
pro-B and pre-B cells, the temporal transition region was elimi-
nated as the entire Igh locus replicated early in S, indicative of the
ﬁring of multiple origins that were otherwise latent in non-B cells.
Hence, this origin-containing region downstream of Tmem121
appeared to demarcate upstream sequences that are under B cell-
speciﬁc Igh regulation fromdownstream sequences under non-Igh
control. Notably, in mature B cells and plasma cells, the temporal
transition regionwas again evident and the replication patternwas
similar to that seen in non-B cells. The change in replication was
paralleled by a change in location of the Igh locus from a position
at the nuclear periphery in non-B cells to away from the nuclear
periphery in pro- and pre-B cells, with resumption of a nuclear
periphery location in B and plasma cells. Analysis of replication
dynamics in a cell line in which the 3′ RR enhancer region had
been deleted, leaving behind the CTCF/Pax5-binding region and
further downstream sequences, showed no difference compared
to wild-type plasma cells (Michaelson et al., 1997). While these
ﬁndings showed that the 3′ RR enhancer region is not essential for
the timing of replication of the Igh locus in plasma cells, inferences
about the role of the CTCF/Pax5-binding region in this process are
not possible.
SUMMARY
Here we have discussed two major modules of the 3′ RR, which
extends ∼40 kb beginning downstream of Cα. The 5′ 28 kb seg-
ment contains four enhancers, which, collectively, support GT,
CSR, and high levels of IgH expression in plasma cells. The
∼10 kb 3′ segment contains a region of high-density CTCF- and
Pax5-binding sites with insulator activity. During B cell devel-
opment, the 3′ RR-its enhancers and CTCF-binding region – is
involved, via loop formation, with various target Igh sequences.
These include: (1) CTCF sites upstream of DH that are essen-
tial for normal VDJ joining and allelic Igh expression in pre-B
cells; (2) I/switch sequences required for GT and CSR in B cells,
and c) JH and Eμ, which support Igh expression in plasma cells.
While 3′ RR enhancers are essential for GT and CSR, as demon-
strated by targeted deletions, independent deletion of at least seven
of an estimated nine CTCF sites in the 3′ RR resulted in only a
mild phenotype (Volpi et al., 2012). We found essentially normal
VDJ joining but with a slight decrease in VH-locus contraction, a
twofold increase in usage of proximalVH7183 genes and an appar-
ent increase in DQ52-JH3 usage. Steps in GT and CSR appeared
generally indistinguishable from wild-type, as was the chromoso-
mal architecture of the 3′ RR assessed by 3C. In all, we conclude
that the CTCF-binding region is a nidus for physical interactions
with Igh targets of important biological consequence. However,
there must be many back-ups that provide functional compensa-
tion to CTCF. These back-ups may include local regulators, such
as CTCF sites associated with other neighboring genes, or proteins
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other than CTCF and/or epigenetic regulators that terminate B
cell-speciﬁc regulation of the Igh locus.
ONGOING KEY QUESTIONS
Which proteins/nucleic acids/other molecules are essential for
loop formation? Are there different kinds of structural and func-
tional loops? What do loops do? Do they engage the Igh locus in
particular subnuclear domains for DNA rearrangements, muta-
tion, etc. during different stages of B cell development? How
does the 3′ RR function?What mediates architectural interactions
among the 3′ RR enhancers themselves and between the enhancer
and CTCF-binding modules? How does loop formation in the Igh
locus relate to loops in other loci? What speciﬁcally does CTCF
contribute to the structure and function of the Igh locus?
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